On August 04, 2022, Cogent Biosciences Inc. (NASDAQ: COGT) opened at $10.79, higher 12.58% from the last session. During the day, the shares moved up to $12.22 and dropped to $10.735 before settling in for the closing price of $10.65. Price fluctuations for COGT have ranged from $3.79 to $12.08 over the past 52 weeks.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Company’s average yearly earnings per share was noted 88.50% at the time writing. With a float of $38.60 million, this company’s outstanding shares have now reached $45.11 million.
The firm has a total of 77 workers. Let’s measure their productivity.
Cogent Biosciences Inc. (COGT) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cogent Biosciences Inc. is 0.01%, while institutional ownership is 63.70%. The most recent insider transaction that took place on Jun 16, was worth 9,900,000. In this transaction 10% Owner of this company bought 1,200,000 shares at a rate of $8.25, taking the stock ownership to the 2,472,124 shares.
Cogent Biosciences Inc. (COGT) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 3/30/2022, the company posted -$0.68 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.52) by -$0.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.59 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 88.50% per share during the next fiscal year.
Cogent Biosciences Inc. (NASDAQ: COGT) Trading Performance Indicators
Check out the current performance indicators for Cogent Biosciences Inc. (COGT). In the past quarter, the stock posted a quick ratio of 10.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.19, a number that is poised to hit -0.65 in the next quarter and is forecasted to reach -2.41 in one year’s time.
Technical Analysis of Cogent Biosciences Inc. (COGT)
Analysing the last 5-days average volume posted by the [Cogent Biosciences Inc., COGT], we can find that recorded value of 0.87 million was lower than the volume posted last year of 1.41 million. As of the previous 9 days, the stock’s Stochastic %D was 48.00%. Additionally, its Average True Range was 0.85.
During the past 100 days, Cogent Biosciences Inc.’s (COGT) raw stochastic average was set at 97.27%, which indicates a significant increase from 89.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.04% in the past 14 days, which was lower than the 117.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.86, while its 200-day Moving Average is $7.86. Now, the first resistance to watch is $12.56. This is followed by the second major resistance level at $13.13. The third major resistance level sits at $14.05. If the price goes on to break the first support level at $11.08, it is likely to go to the next support level at $10.16. Now, if the price goes above the second support level, the third support stands at $9.59.
Cogent Biosciences Inc. (NASDAQ: COGT) Key Stats
There are currently 45,819K shares outstanding in the company with a market cap of 1.06 billion. Presently, the company’s annual sales total 0 K according to its annual income of -72,270 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -30,634 K.